Table 1.
Patient characteristics at baseline (n = 15)
| Characteristic | n or mean ± SD |
|---|---|
| Male/female | 8/7 |
| Age (years) | 64.7 ± 10.5 |
| Body mass index (kg/m2) | 23.7 ± 3.8 |
| Duration of diabetes mellitus (years) | 10.1 ± 7.1 |
| Glycosylated hemoglobin value (%) | 8.56 ± 1.80 |
| Fasting plasma glucose [mg/dL (mmol/L)] | 154 ± 39 (8.5 ± 2.2) |
| Immunoreactive insulin (μU/mL) | 4.95 ± 2.18 |
| Glycoalbumin (%) | 20.3 ± 3.0 |
| Intact proinsulin (pmol/L) | 19.3 ± 5.8 |
| Urinary C-peptide immunoreactivity (μg/day) | 82.5 ± 36.4 |
| HOMA-β | 24.3 ± 16.6 |
| HOMA-IR | 1.86 ± 1.04 |
| Previous antidiabetic medications | |
| Sulfonylureas | 11 |
| Biguanides (metformin) | 6 |
| Thiazolidinedione | 3 |
| α-Glucosidase inhibitor | 1 |
| Glinide | 1 |
| None | 1 |
HOMA-β homeostasis model assessment for β cell function, HOMA-IR homeostasis model assessment for insulin resistance, SD standard deviation